Abstract
Introduction: We examined the prevalence, pathological findings, and oncological outcomes of incidental bladder cancer found on cystoscopy among patients eligible for prostate biopsy (PB). Methods: We retrospectively reviewed 803 patients who underwent cystoscopy prior to PB between January 2010 and September 2020. In cases of bladder tumor-like findings on cystoscopy, biopsy or transurethral resection of the bladder tumor was performed. The primary and secondary outcomes were the prevalence of incidental bladder cancer and pathological and oncological outcomes of incidental bladder cancer, respectively. Results: Incidental findings were observed in 31/803 patients (3.9%). Bladder tumor-like findings were found in 24/803 patients (3%), while 9/803 patients (1.1%) were pathologically diagnosed with urothelial carcinoma. The stage and grade of incidental bladder cancer were pTa in 8/9 patients and pT1 in 1/9 and low grade in 8/9 and high in 1/9, respectively. The median tumor size of the papillary pedunculated type was 0.5 cm. At 26-month median follow-up, no recurrence was observed. Conclusion: Cystoscopy during PB may yield incidental bladder cancer findings, although the prevalence is very low. Incidental bladder cancer was of low stage and grade, which seemed unrelated to survival. Moreover, performing routine cystoscopy in conjunction with PB is not recommended as it may lead to overdiagnosis of low-risk bladder cancer.
References
1.
Siegel
RL
, Miller
KD
, Jemal
A
. Cancer statistics, 2019
. CA A Cancer J Clin
. 2019
;69
(1
):7
–34
. .2.
El-Shater Bosaily
A
, Parker
C
, Brown
LC
, Gabe
R
, Hindley
RG
, Kaplan
R
, , PROMIS – Prostate MR imaging study: a paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer
. Contemp Clin Trials
. 2015
;42
:26
–40
. .3.
Ahmed
HU
, El-Shater Bosaily
A
, Brown
LC
, Gabe
R
, Kaplan
R
, Parmar
MK
, Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
. Lancet
. 2017
;389
(10071
):815
–22
. .4.
Wegelin
O
, van Melick
HHE
, Hooft
L
, Bosch
JLHR
, Reitsma
HB
, Barentsz
JO
, Comparing three different techniques for magnetic resonance imaging-targeted Prostate Biopsies: a systematic review of In-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus Cognitive Registration. Is there a Preferred Technique?
Eur Urol
. 2017
;71
(4
):517
–31
. .5.
Sathianathen
NJ
, Omer
A
, Harriss
E
, Davies
L
, Kasivisvanathan
V
, Punwani
S
, Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data system era: a systematic review and meta-analysis
. Eur Urol
. 2020
;78
(3
):402
–14
. .6.
European Association of Urology Guideline. Available from https://uroweb.org/guideline/prostate-cancer/ Accessed 2020 Nov 30.
7.
Bjurlin
MA
, Carroll
PR
, Eggener
S
, Fulgham
PF
, Margolis
DJ
, Pinto
PA
, Update of the standard operating procedure on the use of multiparametric magnetic resonance imaging for the diagnosis, staging and management of prostate cancer
. J Urol
. 2020
;203
(4
):706
–12
. .8.
Cutaia
G
, Tosto
G
, Cannella
R
, Bruno
A
, Leto
C
, Salvaggio
L
, Prevalence and clinical significance of incidental findings on multiparametric prostate MRI
. Radiol Med
. 2020
;125
(2
):204
–13
. .9.
Sherrer
RL
, Lai
WS
, Thomas
JV
, Nix
JW
, Rais-Bahrami
S
. Incidental findings on multiparametric MRI performed for evaluation of prostate cancer
. Abdom Radiol
. 2018
;43
(3
):696
–701
. .10.
Rayn
KN
, Hale
GR
, Bloom
JB
, Gold
SA
, Carvalho
FLF
, Mehralivand
S
, Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience
. Diagn Interv Radiol
. 2018
;24
(5
):316
–20
. .11.
Barocas
DA
, Boorjian
SA
, Alvarez
RD
, Downs
TM
, Gross
CP
, Hamilton
BD
, Microhematuria: AUA/SUFU guideline
. J Urol
. 2020
;204
(4
):778
–86
. .12.
Tan
WS
, Sarpong
R
, Khetrapal
P
, Rodney
S
, Mostafid
H
, Cresswell
J
, Can renal and bladder ultrasound replace computerized tomography urogram in patients investigated for microscopic hematuria?
J Urol
. 2018
;200
(5
):973
–80
. .13.
Davis
R
, Jones
JS
, Barocas
DA
, Castle
EP
, Lang
EK
, Leveillee
RJ
, Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline
. J Urol
. 2012
;188
(6 Suppl
):2473
–81
.14.
de Cunto Romero
R
, Franca
WA
, Cristiane
BD
, Pascini
CG
, Amin
EC
, Rios
LAS
. Bladder lesions as incidental findings during transurethral resection of the prostate: prevalence, diagnosis, and pathological findings
. World J Urol
. 2012
;39
(6
):1955
–60
.15.
Ramirez
D
, Gupta
A
, Canter
D
, Harrow
B
, Dobbs
RW
, Kucherov
V
, Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer
. BJU Int
. 2016
;117
(5
):783
–6
. .16.
Shephard
EA
, Stapley
S
, Neal
RD
, Rose
P
, Walter
FM
, Hamilton
WT
, Clinical features of bladder cancer in primary care
. Br J Gen Pract
. 2012
;62
(602
):e598
–604
. .17.
Sylvester
RJ
, van der Meijden
AP
, Oosterlinck
W
, Witjes
JA
, Bouffioux
C
, Denis
L
, Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials
. Eur Urol
. 2006
;49
(3
):466
–7
. .18.
Hernández
V
, Llorente
C
, de la Peña
E
, Pérez-Fernández
E
, Guijarro
A
, Sola
I
. Long-term oncological outcomes of an active surveillance program in recurrent low grade Ta bladder cancer
. Urol Oncol
. 2016
;34
(4
):165.e19
–23
. .19.
Lopez-Beltran
A
, Cheng
L
, Montorsi
F
, Scarpelli
M
, Raspollini
MR
, Montironi
R
. Concomitant bladder cancer and prostate cancer: challenges and controversies
. Nat Rev Urol
. 2017
;14
(10
):620
–9
. .20.
Moschini
M
, Zaffuto
E
, Karakiewicz
PI
, Andrea
DD
, Foerster
B
, Abufaraj
M
, External beam radiotherapy increases the risk of bladder cancer when compared with radical prostatectomy in patients affected by prostate cancer: a population-based analysis
. Eur Urol
. 2019
;75
:319
–28
.21.
Herr
HW
. Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?
BJU Int
. 2001
;88
(7
):683
–5
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
